Professor Gideon Hirschfield is recognised globally as a thought leader in liver medicine and recognised by his patients as being a patient centred clinician expert. With experience in tertiary Hepatology care (pre, peri-, and post-transplant) for already nearly 15 years, Gideon provides world class opinion and direction on the management of patients with liver disease. He has published nearly 200 times on Pubmed and has papers spanning basic science, clinical science and clinical trials. He is a recognised leader in Hepatology and well respected speaker and educator.

His clinical practice attracts referrals internationally: expertise spans common and rare liver disease, with special expertise in autoimmune liver disease (primary sclerosing cholangitis, primary biliary cholangitis/cirrhosis, autoimmune hepatitis, IgG4 disease), NAFLD, Wilson disease, Obstetric Hepatology and the care of the liver transplant patient. Gideon has expertise in preparing complex medico-legal reports, and academically has extensive expertise working with biotech/Pharma (small and large).

Gideon is an internationally trained clinician scientist committed wholly to discovery and translational science in liver disease. With undergraduate and clinical training, and practice, spanning the Universities of Oxford, Cambridge, London, Birmingham and Toronto, his drive is for the identification and implementation of effective, personalised therapies for patients with immune and inflammatory mediated liver diseases, delivered through innovative platforms and based on cutting-edge laboratory science.